 BAUDETTE, Minn.--BUSINESS WIRE--ANI Pharmaceuticals, Inc. ANI or the Company Nasdaq:ANIP today announced that the Companys supplemental New Drug Application sNDA for Purified Cortrophin Gel Cortrophin Gel has been accepted by the U.S. Food and Drug Administration FDA for review. FDAs acceptance of our sNDA for Cortrophin Gel marks a significant milestone for ANI. With a PDUFA target action date of October 29, 2021, we are one step closer to bringing a much-needed produ 